Literature DB >> 11982863

Increased production of serum IgA-class antibody to lipid A in Kawasaki disease.

Seiichiro Takeshita1, Hiroko Kawase, Tooru Shimizu, Maki Yoshida, Isao Sekine.   

Abstract

BACKGROUND: The etiology of Kawasaki disease (KD) remains unknown. To investigate whether a conventional bacterial antigen is involved in the pathogenesis of KD, we studied the serum response to lipopolysaccharide (LPS).
METHODS: We measured the serum levels of IgG-, IgM- and IgA-class antibodies (Ab) to lipid A, a toxic site of LPS, using enzyme-linked immunosorbent assay in 20 patients with KD, 11 patients with Gram-negative bacterial infection (GNBI), 27 healthy children and 12 healthy adults.
RESULTS: The serum levels of anti-lipid A IgG, IgM and IgA tended to increase with advancing age in healthy children older than 6 months of age. The mean level of anti-lipid A IgM in the acute phase of GNBI and the mean levels of anti-lipid A IgM and IgA in the acute phase of KD were found to increase significantly, in comparison to the age-matched controls. Furthermore, the mean level of anti-lipid A IgA also showed a significant increase from the acute to the subacute phases of KD. Regarding the IgA-subclass response, higher titers of anti-lipid A specific Ab were seen in the IgA2 subclass than in the IgA1 subclass.
CONCLUSION: These findings indicate that KD patients demonstrate an intense response to lipid A in the IgA, especially IgA2-subclass, thus suggesting that an unusual activation of the mucosal immune response to a ubiquitous antigen derived from Gram-negative bacteria may be involved in the pathogenesis of KD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11982863     DOI: 10.1046/j.1442-200x.2002.01506.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  4 in total

1.  The nonplanar secretory IgA2 and near planar secretory IgA1 solution structures rationalize their different mucosal immune responses.

Authors:  Alexandra Bonner; Adel Almogren; Patricia B Furtado; Michael A Kerr; Stephen J Perkins
Journal:  J Biol Chem       Date:  2008-12-23       Impact factor: 5.157

2.  Study of the autoantibody profile after the acute phase of Kawasaki disease in a cohort of children from North India.

Authors:  R Venkatraman; S Singh; R W Minz
Journal:  Rheumatol Int       Date:  2005-11-25       Impact factor: 2.631

3.  Increased frequency of immunoglobulin (Ig)A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with Kawasaki disease.

Authors:  L Giordani; M G Quaranta; A Marchesi; E Straface; D Pietraforte; A Villani; W Malorni; D Del Principe; M Viora
Journal:  Clin Exp Immunol       Date:  2010-12-22       Impact factor: 4.330

4.  Gastrointestinal presentation of Kawasaki disease: A red flag for severe disease?

Authors:  Marianna Fabi; Elena Corinaldesi; Luca Pierantoni; Elisa Mazzoni; Chiara Landini; Barbara Bigucci; Gina Ancora; Laura Malaigia; Tetyana Bodnar; Giorgia Di Fazzio; Francesca Lami; Enrico Valletta; Cristina Cicero; Giacomo Biasucci; Lorenzo Iughetti; Federico Marchetti; Paola Sogno Valin; Sergio Amarri; Sandra Brusa; Monica Sprocati; Giuseppe Maggiore; Ada Dormi; Paolo Lanzoni; Andrea Donti; Marcello Lanari
Journal:  PLoS One       Date:  2018-09-04       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.